Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CVS Health Corp (NYSE:CVS)

96.55
Delayed Data
As of Jul 22
 -0.40 / -0.41%
Today’s Change
81.37
Today|||52-Week Range
113.65
-1.25%
Year-to-Date
CVS Regular Dividend: CVS began trading ex-dividend on 07/19/16. A $0.425 dividend will be paid to shareholders of record as of 07/21/16.
Barron's Picks And Pans: Pharmacy-Benefit Managers, Mortgage Insurers And More
4:52pm / Benzinga - Paid Partner Content
Better Buy: CVS Health Corp vs. Express Scripts
Jul 20 / MotleyFool.com - Paid Partner Content
3 Stocks That Retirees Should Consider Buying Today
Jul 23 / MotleyFool.com - Paid Partner Content
3 Stocks to Buy and Hold Forever
Jul 15 / MotleyFool.com - Paid Partner Content
Jerome Dodson Goes 3 for 3 in Second Quarter
Jul 21 / GuruFocus News - Paid Partner Content
An Aging Population Makes These 3 Stocks Screaming Buys
Jul 14 / MotleyFool.com - Paid Partner Content
UnitedHealth's Obamacare Shun, Recent Deals, Makes It Attractive for the Future
Jul 20 / TheStreet.com - Paid Partner Content
CVS Health (CVS) Works to Cut Down on Readmission Rates
Jul 11 / Zacks.com - Paid Partner Content
Recent Dip in CVS Shares Presents Buying Opportunity, Analysts Say
Jul 20 / TheStreet.com - Paid Partner Content
Elizabeth Warren: Have tech companies become 'too big to fail'?
Jun 30 / CNNMoney.com

Today’s Trading

Previous close96.95
Today’s open97.08
Day’s range96.20 - 97.14
Volume2,955,734
Average volume (3 months)4,657,955
Market cap$103.7B
Dividend yield1.76%
Data as of 4:03pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+16.72%
Earnings growth (this year)+12.87%
Earnings growth (next 5 years)+14.13%
Revenue growth (last year)+9.99%
P/E ratio21.0
Price/Sales0.72
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
WBAWalgreen-0.35-0.43%
ESRXExpress Scripts Hold...+0.27+0.34%
RADRite Aid Corp-0.04-0.58%
PMCPharMerica Corp+0.06+0.22%
Data as of 4:14pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$1.30
Annual revenue (last year)$153.3B
Annual profit (last year)$5.2B
Net profit margin3.39%

Profile

Sector
Retail Trade
Industry
Drugstore Chains
President, CEO &
Non-Independent Director
Larry J. Merlo
Chief Financial Officer &
Executive Vice President
David M. Denton
Corporate headquarters
Woonsocket, Rhode Island

Forecasts

Partner Offers

Search for Jobs